The role of krüppel-like factors in the reprogramming of somatic cells to induced pluripotent stem cells

Histology and Histopathology

Volumn 24, Issue 10, 2009, Pages 1343-1355

  Nandan, Mandayam O ^a   Yang, Vincent W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ES cells; iPS cells; KLF; Reprogramming; Somatic cells

Indexed keywords

IPS;

KRUPPEL LIKE FACTOR;

ANIMAL; CYTOLOGY; GENETICS; HUMAN; METABOLISM; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; REVIEW; STEM CELL;

ANIMALS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS; STEM CELLS;

EID: 70349449352     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (163)

1. Adam P.J., Regan C.P., Hautmann M.B. and Owens G.K. (2000). Positive- and negative-acting Krüppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J. Biol. Chem. 275, 37798-37806.
2. Alberio R., Campbell K.H. and Johnson A.D. (2006). Reprogramming somatic cells into stem cells. Reproduction 132, 709-720.
3. Alder J.K., Georgantas R.W. 3rd, Hildreth R.L., Kaplan I.M., Morisot S., Yu X., McDevitt M. and Civin C.I. (2008). Krüppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo. J. Immunol. 180, 5645-5652.
4. Anderson K.P., Kern C.B., Crable S.C. and Lingrel J.B. (1995). Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Krüppel-like factor: identification of a new multigene family. Mol. Cell. Biol. 15, 5957-5965.
5. Aoi T., Yae K., Nakagawa M., Ichisaka T., Okita K., Takahashi K., Chiba T. and Yamanaka S. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699-702.
6. Bateman N.W., Tan D., Pestell R.G., Black J.D. and Black A.R. (2004). Intestinal tumor progression is associated with altered function of KLF5. J. Biol. Chem. 279, 12093-12101.
7. Birsoy K., Chen Z. and Friedman J. (2008). Transcriptional regulation of adipogenesis by KLF4. Cell Metab. 7, 339-347.
8. Black A.R., Black J.D. and Azizkhan-Clifford J. (2001). Sp1 and kruppellike factor family of transcription factors in cell growth regulation and cancer. J. Cell Physiol. 188, 143-160.
9. Blok L.J., Grossmann M.E., Perry J.E. and Tindall D.J. (1995). Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol. Endocrinol. 9, 1610-1620.
10. Brembeck F.H. and Rustgi A.K. (2000). The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. J. Biol. Chem. 275, 28230-28239.
11. Bru T., Clarke C., McGrew M.J., Sang H.M., Wilmut I. and Blow J.J. (2008). Rapid induction of pluripotency genes after exposure of human somatic cells to mouse ES cell extracts. Exp. Cell Res. 314, 2634-2642.
12. Carey B.W., Markoulaki S., Hanna J., Saha K., Gao Q., Mitalipova M. and Jaenisch R. (2009). Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl. Acad. Sci. USA 106, 157-162.
13. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S. and Smith A. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655.
14. Chanchevalap S., Nandan M.O., Merlin D. and Yang V.W. (2004). Alltrans retinoic acid inhibits proliferation of intestinal epithelial cells by inhibiting expression of the gene encoding Krüppel-like factor 5. FEBS Lett. 578, 99-105.
15. Chen C., Bhalala H.V., Qiao H. and Dong J.T. (2002). A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene 21, 6567-6572.
16. Chen C., Bhalala H.V., Vessella R.L. and Dong J.T. (2003a). KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 55, 81-88.
17. Chen C., Sun X., Guo P., Dong X.Y., Sethi P., Cheng X., Zhou J., Ling J., Simons J.W., Lingrel J.B. and Dong J.T. (2005). Human Krüppellike factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J. Biol. Chem. 280, 41553-41561.
18. Chen S., Zhang Q., Wu X., Schultz P.G. and Ding S. (2004). Dedifferentiation of lineage-committed cells by a small molecule. J. Am. Chem. Soc. 126, 410-411.
19. Chen X., Johns D.C., Geiman D.E., Marban E., Dang D.T., Hamlin G., Sun R. and Yang V.W. (2001). Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem. 276, 30423-30428.
20. Chen X., Whitney E.M., Gao S.Y. and Yang V.W. (2003b). Transcriptional profiling of Krüppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J. Mol. Biol. 326, 665-677.
21. Chen Y.J., Wu C.Y., Chang C.C., Ma C.J., Li M.C. and Chen C.M. (2008). Nuclear Krüppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. Cancer Biol. Ther. 7, 777-782.
22. Chiambaretta F., De Graeve F., Turet G., Marceau G., Gain P., Dastugue B., Rigal D. and Sapin V. (2004). Cell and tissue specific expression of human Krüppel-like transcription factors in human ocular surface. Mol. Vis. 10, 901-909.
23. Chung Y., Klimanskaya I., Becker S., Marh J., Lu S.J., Johnson J., Meisner L. and Lanza R. (2006). Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439, 216-219.
24. Conkright M.D., Wani M.A., Anderson K.P. and Lingrel J.B. (1999). A gene encoding an intestinal-enriched member of the Krüppel-like factor family expressed in intestinal epithelial cells. Nucleic Acids Res. 27, 1263-1270.
25. Cook T., Gebelein B., Mesa K., Mladek A. and Urrutia R. (1998). Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth. J. Biol. Chem. 273, 25929-25936.
26. Cowan C.A., Atienza J., Melton D.A. and Eggan K. (2005). Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309, 1369-1373.
27. Cullingford T.E., Butler M.J., Marshall A.K., Tham el L., Sugden P.H. and Clerk A. (2008). Differential regulation of Krüppel-like factor family transcription factor expression in neonatal rat cardiac myocytes: effects of endothelin-1, oxidative stress and cytokines. Biochim. Biophys. Acta 1783, 1229-1236.
28. Dang D.T., Bachman K.E., Mahatan C.S., Dang L.H., Giardiello F.M. and Yang V.W. (2000a). Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett. 476, 203-207.
29. Dang D.T., Pevsner J. and Yang V.W. (2000b). The biology of the mammalian Krüppel-like family of transcription factors. Int. J. Biochem. Cell Biol. 32, 1103-1121.
30. Dang D.T., Zhao W., Mahatan C.S., Geiman D.E. and Yang V.W. (2002). Opposing effects of Krüppel-like factor 4 (gut-enriched Krüppel-like factor) and Krüppel-like factor 5 (intestinal-enriched Krüppel-like factor) on the promoter of the Krüppel-like factor 4 gene. Nucleic Acids Res. 30, 2736-2741.
31. Dani C., Chambers I., Johnstone S., Robertson M., Ebrahimi B., Saito M., Taga T., Li M., Burdon T., Nichols J. and Smith A. (1998). Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. Dev. Biol. 203, 149-162.
32. Deb K., Sivaguru M., Yong H.Y. and Roberts R.M. (2006). Cdx2 gene expression and trophectoderm lineage specification in mouse embryos. Science 311, 992-996.
33. Di Stefano B., Prigione A. and Broccoli V. (2008). Efficient genetic reprogramming of unmodified somatic neural progenitors uncovers the essential requirement of Oct4 and Klf4. Stem Cells Dev. (In Press).
34. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., Wichterle H., Henderson C.E. and Eggan K. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221.
35. Ding S. and Schultz P.G. (2004). A role for chemistry in stem cell biology. Nat. Biotechnol. 22, 833-840.
36. Dong J.T. (2001). Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev. 20, 173-193.
37. Du J.X., Bialkowska A.B., McConnell B.B. and Yang V.W. (2008). SUMOylation regulates nuclear localization of Krüppel-like factor 5. J. Biol. Chem. 283, 31991-32002.
38. Du J.X., Yun C.C., Bialkowska A. and Yang V.W. (2007). Protein inhibitor of activated STAT1 interacts with and up-regulates activities of the pro-proliferative transcription factor Krüppel-like factor 5. J. Biol. Chem. 282, 4782-4793.
39. Egli D., Rosains J., Birkhoff G. and Eggan K. (2007). Developmental reprogramming after chromosome transfer into mitotic mouse zygotes. Nature 447, 679-685.
40. Ema M., Mori D., Niwa H., Hasegawa Y., Yamanaka Y., Hitoshi S., Mimura J., Kawabe Y., Hosoya T., Morita M., Shimosato D., Uchida K., Suzuki N., Yanagisawa J., Sogawa K., Rossant J., Yamamoto M., Takahashi S. and Fujii-Kuriyama Y. (2008). Krüppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell 3, 555-567.
41. Eminli S., Utikal J., Arnold K., Jaenisch R. and Hochedlinger K. (2008). Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 26, 2467-2474.
42. Ernst M., Oates A. and Dunn A.R. (1996). Gp130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. J. Biol. Chem. 271, 30136-30143.
43. Evans M. (2005). Ethical sourcing of human embryonic stem cells-- rational solutions? Nat Rev Mol. Cell. Biol. 6, 663-667.
44. Feinberg M.W., Wara A.K., Cao Z., Lebedeva M.A., Rosenbauer F., Iwasaki H., Hirai H., Katz J.P., Haspel R.L., Gray S., Akashi K., Segre J., Kaestner K.H., Tenen D.G. and Jain M.K. (2007). The Krüppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J. 26, 4138-4148.
45. Foster K.W., Frost A.R., McKie-Bell P., Lin C.Y., Engler J.A., Grizzle W.E. and Ruppert J.M. (2000). Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 60, 6488-6495.
46. Foster K.W., Liu Z., Nail C.D., Li X., Fitzgerald T.J., Bailey S.K., Frost A.R., Louro I.D., Townes T.M., Paterson A.J., Kudlow J.E., Lobo-Ruppert S.M. and Ruppert J.M. (2005). Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24, 1491-1500.
47. Foster K.W., Ren S., Louro I.D., Lobo-Ruppert S.M., McKie-Bell P., Grizzle W., Hayes M.R., Broker T.R., Chow L.T. and Ruppert J.M. (1999). Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ. 10, 423-434.
48. Freberg C.T., Dahl J.A., Timoskainen S. and Collas P. (2007). Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol. Biol. Cell 18, 1543-1553.
49. Fruman D.A., Ferl G.Z., An S.S., Donahue A.C., Satterthwaite A.B. and Witte O.N. (2002). Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes. Proc. Natl. Acad. Sci. USA 99, 359-364.
50. Garrett-Sinha L.A., Eberspaecher H., Seldin M.F. and de Crombrugghe B. (1996). A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J. Biol. Chem. 271, 31384-31390.
51. Geiman D.E., Ton-That H., Johnson J.M. and Yang V.W. (2000). Transactivation and growth suppression by the gut-enriched Krüppel-like factor (Krüppel-like factor 4) are dependent on acidic amino acid residues and protein-protein interaction. Nucleic Acids Res. 28, 1106-1113.
52. Ghaleb A.M., Aggarwal G., Bialkowska A.B., Nandan M.O. and Yang V.W. (2008). Notch inhibits expression of the kruppel-like factor 4 tumor suppressor in the intestinal epithelium. Mol. Cancer Res. 6, 1920-1927.
53. Ghaleb A.M., Katz J.P., Kaestner K.H., Du J.X. and Yang V.W. (2007a). Krüppel-like factor 4 exhibits antiapoptotic activity following gammaradiation- induced DNA damage. Oncogene 26, 2365-2373.
54. Ghaleb A.M., McConnell B.B., Nandan M.O., Katz J.P., Kaestner K.H. and Yang V.W. (2007b). Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res. 67, 7147-7154.
55. Ghaleb A.M., Nandan M.O., Chanchevalap S., Dalton W.B., Hisamuddin I.M. and Yang V.W. (2005). Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res. 15, 92-96.
56. Giefing M., Wierzbicka M., Rydzanicz M., Cegla R., Kujawski M. and Szyfter K. (2008). Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors. Neoplasma 55, 55-60.
57. Gregorieff A. and Clevers H. (2005). Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 19, 877-890.
58. Guo P., Dong X.Y., Zhang X., Zhao K.W., Sun X., Li Q. and Dong J.T. (2008). Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification. J. Biol. Chem. (In Press).
59. Hanna J., Markoulaki S., Schorderet P., Carey B.W., Beard C., Wernig M., Creyghton M.P., Steine E.J., Cassady J.P., Foreman R., Lengner C.J., Dausman J.A. and Jaenisch R. (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133, 250-264.
60. Hinnebusch B.F., Siddique A., Henderson J.W., Malo M.S., Zhang W., Athaide C.P., Abedrapo M.A., Chen X., Yang V.W. and Hodin R.A. (2004). Enterocyte differentiation marker intestinal alkaline phosphatase is a target gene of the gut-enriched Krüppel-like factor. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G23-30.
61. Huang C.C., Liu Z., Li X., Bailey S.K., Nail C.D., Foster K.W., Frost A.R., Ruppert J.M. and Lobo-Ruppert S.M. (2005). KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol. Ther. 4, 1401-1408.
62. Imataka H., Sogawa K., Yasumoto K., Kikuchi Y., Sasano K., Kobayashi A., Hayami M. and Fujii-Kuriyama Y. (1992). Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene. EMBO J. 11, 3663-3671.
63. Jenkins T.D., Opitz O.G., Okano J. and Rustgi A.K. (1998). Transactivation of the human keratin 4 and Epstein-Barr virus ED-L2 promoters by gut-enriched Krüppel-like factor. J. Biol. Chem. 273, 10747-10754.
64. Jiang J., Chan Y.S., Loh Y.H., Cai J., Tong G.Q., Lim C.A., Robson P., Zhong S. and Ng H.H. (2008). A core Klf circuitry regulates selfrenewal of embryonic stem cells. Nat. Cell Biol. 10, 353-360.
65. Kaczynski J., Cook T. and Urrutia R. (2003). Sp1- and Krüppel-like transcription factors. Genome Biol. 4, 206.
66. Katz J.P., Perreault N., Goldstein B.G., Actman L., McNally S.R., Silberg D.G., Furth E.E. and Kaestner K.H. (2005). Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 128, 935-945.
67. Katz J.P., Perreault N., Goldstein B.G., Lee C.S., Labosky P.A., Yang V.W. and Kaestner K.H. (2002). The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129, 2619-2628.
68. Kawai-Kowase K., Kurabayashi M., Hoshino Y., Ohyama Y. and Nagai R. (1999). Transcriptional activation of the zinc finger transcription factor BTEB2 gene by Egr-1 through mitogen-activated protein kinase pathways in vascular smooth muscle cells. Circ. Res. 85, 787-795.
69. Kim J., Chu J., Shen X., Wang J. and Orkin S.H. (2008a). An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132, 1049-1061.
70. Kim J.B., Zaehres H., Wu G., Gentile L., Ko K., Sebastiano V., Arauzo-Bravo M.J., Ruau D., Han D.W., Zenke M. and Scholer H.R. (2008b). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454, 646-650.
71. Koritschoner N.P., Bocco J.L., Panzetta-Dutari G.M., Dumur C.I., Flury A. and Patrito L.C. (1997). A novel human zinc finger protein that interacts with the core promoter element of a TATA box-less gene. J. Biol. Chem. 272, 9573-9580.
72. Kwak M.K., Lee H.J., Hur K., Park do J., Lee H.S., Kim W.H., Lee K.U., Choe K.J., Guilford P. and Yang H.K. (2008). Expression of Krüppellike factor 5 in human gastric carcinomas. J. Cancer Res. Clin. Oncol. 134, 163-167.
73. Li Y., McClintick J., Zhong L., Edenberg H.J., Yoder M.C. and Chan R.J. (2005). Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105, 635-637.
74. Lowry W.E., Richter L., Yachechko R., Pyle A.D., Tchieu J., Sridharan R., Clark A.T. and Plath K. (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA 105, 2883-2888.
75. Mahatan C.S., Kaestner K.H., Geiman D.E. and Yang V.W. (1999). Characterization of the structure and regulation of the murine gene encoding gut-enriched Krüppel-like factor (Krüppel-like factor 4). Nucleic Acids Res. 27, 4562-4569.
76. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., Stadtfeld M., Yachechko R., Tchieu J., Jaenisch R., Plath K. and Hochedlinger K. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70.
77. Maruyama M., Ichisaka T., Nakagawa M. and Yamanaka S. (2005). Differential roles for Sox15 and Sox2 in transcriptional control in mouse embryonic stem cells. J. Biol. Chem. 280, 24371-24379.
78. Matsumura T., Suzuki T., Aizawa K., Munemasa Y., Muto S., Horikoshi M. and Nagai R. (2005). The deacetylase HDAC1 negatively regulates the cardiovascular transcription factor Krüppel-like factor 5 through direct interaction. J. Biol. Chem. 280, 12123-12129.
79. Mauritz C., Schwanke K., Reppel M., Neef S., Katsirntaki K., Maier L.S., Nguemo F., Menke S., Haustein M., Hescheler J., Hasenfuss G. and Martin U. (2008). Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118, 507-517.
80. McConnell B.B., Ghaleb A.M., Nandan M.O. and Yang V.W. (2007). The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 29, 549-557.
81. McConnell B.B., Klapproth J.M., Sasaki M., Nandan M.O. and Yang V.W. (2008). Krüppel-like factor 5 mediates transmissible murine colonic hyperplasia caused by Citrobacter rodentium infection. Gastroenterology 134, 1007-1016.
82. Meissner A. and Jaenisch R. (2006). Generation of nuclear transferderived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature 439, 212-215.
83. Miller I.J. and Bieker J.J. (1993). A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins. Mol. Cell. Biol. 13, 2776-2786.
84. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M. and Yamanaka S. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642.
85. Miyamoto S., Suzuki T., Muto S., Aizawa K., Kimura A., Mizuno Y., Nagino T., Imai Y., Adachi N., Horikoshi M. and Nagai R. (2003). Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain. Mol. Cell. Biol. 23, 8528-8541.
86. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N. and Yamanaka S. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106.
87. Nandan M.O., Chanchevalap S., Dalton W.B. and Yang V.W. (2005). Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation. FEBS Lett. 579, 4757-4762.
88. Nandan M.O., McConnell B.B., Ghaleb A.M., Bialkowska A.B., Sheng H., Shao J., Babbin B.A., Robine S. and Yang V.W. (2008). Krüppellike factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology 134, 120-130.
89. Nandan M.O., Yoon H.S., Zhao W., Ouko L.A., Chanchevalap S. and Yang V.W. (2004). Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. Oncogene 23, 3404-3413.
90. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., Matsuoka S., Yamanaka S. and Yamashita J.K. (2008). Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118, 498-506.
91. Niwa H., Burdon T., Chambers I. and Smith A. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048-2060.
92. Ohnishi S., Laub F., Matsumoto N., Asaka M., Ramirez F., Yoshida T. and Terada M. (2000). Developmental expression of the mouse gene coding for the Krüppel-like transcription factor KLF5. Dev. Dyn. 217, 421-429.
93. Oishi Y., Manabe I., Tobe K., Ohsugi M., Kubota T., Fujiu K., Maemura K., Kubota N., Kadowaki T. and Nagai R. (2008). SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta. Nat. Med. 14, 656-666.
94. Oishi Y., Manabe I., Tobe K., Tsushima K., Shindo T., Fujiu K., Nishimura G., Maemura K., Yamauchi T., Kubota N., Suzuki R., Kitamura T., Akira S., Kadowaki T. and Nagai R. (2005). Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Meab. 1, 27-39.
95. Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M. and Hamada H. (1990). A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60, 461-472.
96. Okano J., Opitz O.G., Nakagawa H., Jenkins T.D., Friedman S.L. and Rustgi A.K. (2000). The Krüppel-like transcriptional factors Zf9 and GKLF coactivate the human keratin 4 promoter and physically interact. FEBS Lett. 473, 95-100.
97. Okita K., Ichisaka T. and Yamanaka S. (2007). Generation of germlinecompetent induced pluripotent stem cells. Nature 448, 313-317.
98. Okita K., Nakagawa M., Hyenjong H., Ichisaka T. and Yamanaka S. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949-953.
99. Pandya A.Y., Talley L.I., Frost A.R., Fitzgerald T.J., Trivedi V., Chakravarthy M., Chhieng D.C., Grizzle W.E., Engler J.A., Krontiras H., Bland K.I., LoBuglio A.F., Lobo-Ruppert S.M. and Ruppert J.M. (2004). Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin. Cancer Res. 10, 2709-2719.
100. Panigada M., Porcellini S., Sutti F., Doneda L., Pozzoli O., Consalez G.G., Guttinger M. and Grassi F. (1999). GKLF in thymus epithelium as a developmentally regulated element of thymocyte-stroma crosstalk. Mech. Dev. 81, 103-113.
101. Parisi S., Passaro F., Aloia L., Manabe I., Nagai R., Pastore L. and Russo T. (2008). Klf5 is involved in self-renewal of mouse embryonic stem cells. J. Cell Sci. 121, 2629-2634.
102. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K. and Daley G.Q. (2008a). Disease-specific induced pluripotent stem cells. Cell 134, 877-886.
103. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W. and Daley G.Q. (2008b). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146.
104. Pearson R., Fleetwood J., Eaton S., Crossley M. and Bao S. (2008). Krüppel-like transcription factors: a functional family. Int. J. Biochem. Cell Biol. 40, 1996-2001.
105. Philipsen S. and Suske G. (1999). A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 27, 2991-3000.
106. Ratziu V., Lalazar A., Wong L., Dang Q., Collins C., Shaulian E., Jensen S. and Friedman S.L. (1998). Zf9, a Krüppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc. Natl. Acad. Sci. USA 95, 9500-9505.
107. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A. and Bongso A. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404.
108. Reya T. and Clevers H. (2005). Wnt signalling in stem cells and cancer. Nature 434, 843-850.
109. Rowland B.D., Bernards R. and Peeper D.S. (2005). The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 7, 1074-1082.
110. Rowland B.D. and Peeper D.S. (2006). KLF4, p21 and contextdependent opposing forces in cancer. Nat. Rev. Cancer 6, 11-23.
111. Scholer H.R., Dressler G.R., Balling R., Rohdewohld H. and Gruss P. (1990). Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 9, 2185-2195.
112. Schuh R., Aicher W., Gaul U., Cote S., Preiss A., Maier D., Seifert E., Nauber U., Schroder C. and Kemler R. (1986). A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Krüppel, a Drosophila segmentation gene. Cell 47, 1025-1032.
113. Segre J.A., Bauer C. and Fuchs E. (1999). Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22, 356-360.
114. Shi H., Zhang Z., Wang X., Liu S. and Teng C.T. (1999). Isolation and characterization of a gene encoding human Krüppel-like factor 5 (IKLF): binding to the CAAT/GT box of the mouse lactoferrin gene promoter. Nucleic Acids Res. 27, 4807-4815.
115. Shi W., Zakhartchenko V. and Wolf E. (2003). Epigenetic reprogramming in mammalian nuclear transfer. Differentiation 71, 91-113.
116. Shi Y., Desponts C., Do J.T., Hahm H.S., Scholer H.R. and Ding S. (2008). Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568-574.
117. Shie J.L., Chen Z.Y., Fu M., Pestell R.G. and Tseng C.C. (2000). Gutenriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res. 28, 2969-2976.
118. Shields J.M. and Yang V.W. (1997). Two potent nuclear localization signals in the gut-enriched Krüppel-like factor define a subfamily of closely related Krüppel proteins. J. Biol. Chem. 272, 18504-18507.
119. Shields J.M. and Yang V.W. (1998). Identification of the DNA sequence that interacts with the gut-enriched Krüppel-like factor. Nucleic Acids Res. 26, 796-802.
120. Shields J.M., Christy R.J. and Yang V.W. (1996). Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J. Biol. Chem. 271, 20009-20017.
121. Shindo T., Manabe I., Fukushima Y., Tobe K., Aizawa K., Miyamoto S., Kawai-Kowase K., Moriyama N., Imai Y., Kawakami H., Nishimatsu H., Ishikawa T., Suzuki T., Morita H., Maemura K., Sata M., Hirata Y., Komukai M., Kagechika H., Kadowaki T., Kurabayashi M. and Nagai R. (2002). Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med. 8, 856-863.
122. Smith A.G., Heath J.K., Donaldson D.D., Wong G.G., Moreau J., Stahl M. and Rogers D. (1988). Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688-690.
123. Sogawa K., Imataka H., Yamasaki Y., Kusume H., Abe H. and Fujii-Kuriyama Y. (1993). cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. Nucleic Acids Res. 21, 1527-1532.
124. Stadtfeld M., Brennand K. and Hochedlinger K. (2008a). Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr. Biol. 18, 890-894.
125. Stadtfeld M., Nagaya M., Utikal J., Weir G. and Hochedlinger K. (2008b). Induced pluripotent stem cells generated without viral integration. Science 322, 945-949.
126. Stewart C.L., Kaspar P., Brunet L.J., Bhatt H., Gadi I., Kontgen F. and Abbondanzo S.J. (1992). Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359, 76-79.
127. Sun R., Chen X. and Yang V.W. (2001). Intestinal-enriched Krüppel-like factor (Krüppel-like factor 5) is a positive regulator of cellular proliferation. J. Biol. Chem. 276, 6897-6900.
128. Sur I., Unden A.B. and Toftgard R. (2002). Human Krüppel-like factor5/KLF5: synergy with NF-kappaB/Rel factors and expression in human skin and hair follicles. Eur. J. Cell Biol. 81, 323-334.
129. Swamynathan S.K., Katz J.P., Kaestner K.H., Ashery-Padan R., Crawford M.A. and Piatigorsky J. (2007). Conditional deletion of the mouse Klf4 gene results in corneal epithelial fragility, stromal edema, and loss of conjunctival goblet cells. Mol. Cell. Biol. 27, 182-194.
130. Tada M., Tada T., Lefebvre L., Barton S.C. and Surani M.A. (1997). Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J. 16, 6510-6520.
131. Takahashi K. and Yamanaka S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
132. Taranger C.K., Noer A., Sorensen A.L., Hakelien A.M., Boquest A.C. and Collas P. (2005). Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol. Cell 16, 5719-5735.
133. Tokuzawa Y., Kaiho E., Maruyama M., Takahashi K., Mitsui K., Maeda M., Niwa H. and Yamanaka S. (2003). Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol. Cell. Biol. 23, 2699-2708.
134. Ton-That H., Kaestner K.H., Shields J.M., Mahatanankoon C.S. and Yang V.W. (1997). Expression of the gut-enriched Krüppel-like factor gene during development and intestinal tumorigenesis. FEBS Lett. 419, 239-243.
135. Tong D., Czerwenka K., Heinze G., Ryffel M., Schuster E., Witt A., Leodolter S. and Zeillinger R. (2006). Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin. Cancer Res. 12, 2442-2448.
136. Turner J. and Crossley M. (1999). Mammalian Krüppel-like transcription factors: more than just a pretty finger. Trends Biochem. Sci. 24, 236-240.
137. Wakayama T., Perry A.C., Zuccotti M., Johnson K.R. and Yanagimachi R. (1998). Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394, 369-374.
138. Watanabe N., Kurabayashi M., Shimomura Y., Kawai-Kowase K., Hoshino Y., Manabe I., Watanabe M., Aikawa M., Kuro-o M., Suzuki T., Yazaki Y. and Nagai R. (1999). BTEB2, a Krüppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circ. Res. 85, 182-191.
139. Wernig M., Lengner C.J., Hanna J., Lodato M.A., Steine E., Foreman R., Staerk J., Markoulaki S. and Jaenisch R. (2008a). A druginducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26, 916-924.
140. Wernig M., Meissner A., Cassady J.P. and Jaenisch R. (2008b). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10-12.
141. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E. and Jaenisch R. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324.
142. Wernig M., Zhao J.P., Pruszak J., Hedlund E., Fu D., Soldner F., Broccoli V., Constantine-Paton M., Isacson O. and Jaenisch R. (2008c). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105, 5856-5861.
143. Whitney E.M., Ghaleb A.M., Chen X. and Yang V.W. (2006). Transcriptional profiling of the cell cycle checkpoint gene kruppel-like factor 4 reveals a global inhibitory function in macromolecular biosynthesis. Gene Expr. 13, 85-96.
144. Williams R.L., Hilton D.J., Pease S., Willson T.A., Stewart C.L., Gearing D.P., Wagner E.F., Metcalf D., Nicola N.A. and Gough N.M. (1988). Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-687.
145. Wilmut I., Schnieke A.E., McWhir J., Kind A.J. and Campbell K.H. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810-813.
146. Xu J., Lu B., Xu F., Gu H., Fang Y., Huang Q. and Lai M. (2008). Dynamic down-regulation of Krüppel-like factor 4 in colorectal adenoma-carcinoma sequence. J. Cancer Res. Clin. Oncol. 134, 891-898.
147. Yamanaka S. (2007). Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1, 39-49.
148. Yet S.F., McA'Nulty M.M., Folta S.C., Yen H.W., Yoshizumi M., Hsieh C.M., Layne M.D., Chin M.T., Wang H., Perrella M.A., Jain M.K. and Lee M.E. (1998). Human EZF, a Krüppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J. Biol. Chem. 273, 1026-1031.
149. Ying Q.L., Nichols J., Chambers I. and Smith A. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292.
150. Yoon H.S. and Yang V.W. (2004). Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage. J. Biol. Chem. 279, 5035-5041.
151. Yoon H.S., Chen X. and Yang V.W. (2003). Krüppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J. Biol. Chem. 278, 2101-2105.
152. Yoon H.S., Ghaleb A.M., Nandan M.O., Hisamuddin I.M., Dalton W.B. and Yang V.W. (2005). Krüppel-like factor 4 prevents centrosome amplification following gamma-irradiation-induced DNA damage. Oncogene 24, 4017-4025.
153. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T., Hirabayashi T., Yoneda Y., Tanaka K., Wang W.Z., Mori C., Shiota K., Yoshida N. and Kishimoto T. (1996). Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 93, 407-411.
154. Yoshida T., Gan Q. and Owens G.K. (2008a). Krüppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am. J. Physiol. Cell. Physiol. 295, C1175-1182.
155. Yoshida T., Kaestner K.H. and Owens G.K. (2008b). Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ. Res. 102, 1548-1557.
156. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin, II and Thomson J.A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
157. Yusuf I., Kharas M.G., Chen J., Peralta R.Q., Maruniak A., Sareen P., Yang V.W., Kaestner K.H. and Fruman D.A. (2008). KLF4 is a FOXO target gene that suppresses B cell proliferation. Int. Immunol. 20, 671-681.
158. Zhang W., Shields J.M., Sogawa K., Fujii-Kuriyama Y. and Yang V.W. (1998). The gut-enriched Krüppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. J. Biol. Chem. 273, 17917-17925.
159. Zhang W., Geiman D.E., Shields J.M., Dang D.T., Mahatan C.S., Kaestner K.H., Biggs J.R., Kraft A.S. and Yang V.W. (2000). The gut-enriched Krüppel-like factor (Krüppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J. Biol. Chem. 275, 18391-18398.
160. Zhang W., Chen X., Kato Y., Evans P.M., Yuan S., Yang J., Rychahou P.G., Yang V.W., He X., Evers B.M. and Liu C. (2006). Novel cross talk of Krüppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol. Cell. Biol. 26, 2055-2064.
161. Zhang Z. and Teng C.T. (2003). Phosphorylation of Krüppel-like factor 5 (KLF5/IKLF) at the CBP interaction region enhances its transactivation function. Nucleic Acids Res. 31, 2196-2208.
162. Zhao W., Hisamuddin I.M., Nandan M.O., Babbin B.A., Lamb N.E. and Yang V.W. (2004). Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 23, 395-402.
163. Ziemer L.T., Pennica D. and Levine A.J. (2001). Identification of a mouse homolog of the human BTEB2 transcription factor as a betacatenin- independent Wnt-1-responsive gene. Mol. Cell. Biol 21, 562-574.